Departments of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Sciences and Medical School, Nagoya City University, Nagoya, Japan.
Clin Otolaryngol. 2021 Mar;46(2):325-331. doi: 10.1111/coa.13671. Epub 2020 Dec 8.
Facial nerve decompression is a salvage treatment for Bell's palsy patients for whom a poor prognosis is anticipated with standard medical treatment. The transmastoid approach is a frequently performed approach, but it remains unknown if this surgery is effective when the ossicular chain is preserved. This study aimed to determine the efficacy of facial nerve decompression using the transmastoid approach in Bell's palsy.
DESIGN, SETTING AND PARTICIPANTS: This retrospective study included patients who had undergone transmastoid facial nerve decompression with ossicular chain preservation and patients who met the criteria for surgery, but received only medical treatment between January 2007 and May 2019, at a single centre.
Attainment of House-Brackmann grade I at 12 months after onset of facial palsy.
The recovery rate to House-Brackmann grade I in the decompression group in the early phase (≤18 days after onset) was higher than that of the medical treatment group, although the difference was not significant (70% vs 47%, P = .160). However, within this early surgery group, a subgroup of cases with ≥95% facial nerve degeneration demonstrated a significant improvement in recovery rate (73% vs 30%, P = .018). Among surgeries performed in the late phase (≥19 days), only a subgroup with ≥95% facial nerve degeneration was available for analysis, and the difference in recovery rate was not significant compared with medical treatment alone (26% vs 30%, P = 1.00). Post-surgical hearing evaluation demonstrated that average hearing deterioration was 1.3 dB which was non-significant, suggesting this procedure does not cause hearing loss.
Transmastoid facial nerve decompression with ossicular chain preservation in the early phase after symptom-onset is an effective salvage treatment for severe Bell's palsy with ≥95% facial nerve degeneration.
面神经减压术是一种挽救治疗方法,适用于那些经标准药物治疗后预后不佳的贝尔氏面瘫患者。乳突入路是一种常用的手术方法,但目前尚不清楚在保持听小骨链完整的情况下,这种手术是否有效。本研究旨在确定经乳突面神经减压术治疗贝尔氏面瘫的疗效。
设计、设置和参与者:这是一项回顾性研究,纳入了 2007 年 1 月至 2019 年 5 月在单一中心接受经乳突面神经减压术且保留听小骨链的患者,以及符合手术标准但仅接受药物治疗的患者。
面瘫发病后 12 个月达到 House-Brackmann 分级 I 级。
早期(发病后≤18 天)减压组达到 House-Brackmann 分级 I 级的恢复率高于药物治疗组,但差异无统计学意义(70%比 47%,P=0.160)。然而,在这个早期手术组中,面神经退变≥95%的亚组的恢复率显著提高(73%比 30%,P=0.018)。在晚期(≥19 天)手术中,仅面神经退变≥95%的亚组可用于分析,与单独药物治疗相比,恢复率差异无统计学意义(26%比 30%,P=1.00)。术后听力评估显示,平均听力恶化 1.3dB,无统计学意义,提示该手术不会导致听力损失。
发病后早期行乳突面神经减压术并保留听小骨链是治疗面神经退变≥95%的重度贝尔氏面瘫的有效挽救治疗方法。